Comparison of different insulin regimens in elderly patients with NIDDM

Diabetes Care
B H WolffenbuttelA C Nieuwenhuijzen Kruseman

Abstract

To compare the metabolic effects of three different frequently used regimens of insulin administration on blood glucose control and serum lipids, and the costs associated with this treatment, in subjects with NIDDM, who were poorly controlled with oral antihyperglycemic agents. We studied 95 elderly patients with NIDDM (age 68 +/- 9 years, BMI 26.0 +/- 4.6 kg/m2, and median time since diagnosis of diabetes 9 years [range 1-37]; 37 men, 58 women), who were poorly controlled, despite diet and maximal doses of oral antihyperglycemic agents. Three insulin administration regimens were compared during a 6-month period: patients were randomized for treatment with a two-injection scheme (regimen A) or a combination of glibenclamide with one injection of NPH insulin, administered either at bedtime (regimen B) or before breakfast (regimen C), and insulin treatment was mainly instituted in an outpatient setting. After 6 months of insulin treatment, fasting blood glucose of the total patient population had decreased from an average of 14.1 +/- 2.2 to 8.3 +/- 2.0 mmol/L (P < 0.001), and HbA1c fell from 11.0 +/- 1.3 to 8.3 +/- 1.2% (P < 0.001); 34 patients reached HbA1c levels below 8.0%, 25 of them even below 7.5%. With two insulin injectio...Continue Reading

Citations

Feb 22, 2012·Zeitschrift für Gerontologie und Geriatrie·A-K Meyer
Dec 12, 2003·Metabolism: Clinical and Experimental·Ana María WägnerAntonio Pérez
Jul 1, 1997·Baillière's Clinical Endocrinology and Metabolism·A J Scheen
Feb 24, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·G S Meneilly, D Tessier
Apr 4, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Adrian N C LauCatherine H Y Yu
Mar 19, 2003·Drugs & Aging·Joël Belmin, Paul Valensi
Nov 18, 2011·Expert Opinion on Pharmacotherapy·Edoardo MannucciAndrea Rossi
May 16, 2014·Canadian Journal of Diabetes·Graydon S MeneillyDaniel Tessier
Nov 12, 2010·Diabetes Research and Clinical Practice·Hiroki YokoyamaMasakazu Haneda
Jan 18, 2006·Diabetes & Metabolism·V Lassmann-Vague
Jan 18, 2006·Diabetes & Metabolism·J Doucet
Apr 4, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·M J DaviesI G Lawrence
Nov 3, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·A Nybäck-NakellL Landstedt-Hallin
Apr 24, 2001·Diabetes Care·H Yki-Järvinen
Jan 11, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A C Chazan, M B Gomes
Aug 1, 2000·Hospital Practice·H Yki-Järvinen
Jul 17, 2018·International Journal of Endocrinology and Metabolism·Hengameh AbdiAtieh Amouzegar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.